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There continues to be a need for developing efficient and environmentally friendly treatments for Bacillus anthracis, the caus-
ative agent of anthrax. One emerging approach for inactivation of vegetative B. anthracis is the use of bacteriophage endolysins
or lytic enzymes encoded by bacterial genomes (autolysins) with highly evolved specificity toward bacterium-specific peptidogly-
can cell walls. In this work, we performed in silico analysis of the genome of Bacillus anthracis strain Ames, using a consensus
binding domain amino acid sequence as a probe, and identified a novel lytic enzyme that we termed AmiBA2446. This enzyme
exists as a homodimer, as determined by size exclusion studies. It possesses N-acetylmuramoyl-L-alanine amidase activity, as
determined from liquid chromatography-mass spectrometry (LC-MS) analysis of muropeptides released due to the enzymatic
digestion of peptidoglycan. Phylogenetic analysis suggested that AmiBA2446 was an autolysin of bacterial origin. We character-
ized the effects of enzyme concentration and phase of bacterial growth on bactericidal activity and observed close to a 5-log re-
duction in the viability of cells of Bacillus cereus 4342, a surrogate for B. anthracis. We further tested the bactericidal activity of
AmiBA2446 against various Bacillus species and demonstrated significant activity against B. anthracis and B. cereus strains. We
also demonstrated activity against B. anthracis spores after pretreatment with germinants. AmiBA2446 enzyme was also stable
in solution, retaining its activity after 4 months of storage at room temperature.
Bactericidal enzymes, including bacteriophage endolysins, andlytic enzymes encoded by bacterial genomes (autolysins),
have been the subject of increased interest in the past decade,
particularly in light of emerging antibiotic resistance (1–5). Bac-
teriophage endolysins are expressed late during the bacteriophage
life cycle, hydrolyzing the bacterial cell wall peptidoglycan to allow
viral progeny to escape the host cell. Practical interest in the use of
these proteins against Gram-positive bacteria has emerged due to
their ability to degrade the bacterial cell wall when applied exoge-
nously (6). Their therapeutic use against human and animal
pathogens (7) and their use for decontamination in the food in-
dustry (8, 9) have been proposed.
Recent analyses of gene sequences and protein structures of
bacterium-derived lytic enzymes have shown that these enzymes
share many of the attractive characteristics of bacteriophage en-
dolysins (5, 10, 11). Lytic enzymes from a diverse spectrum of
bacterial species have been characterized to date (2, 8, 12). Lytic
enzymes are an enzymatically diverse group of proteins. Most of
these enzymes have a modular structure, typically with an N-ter-
minal catalytic domain and a C-terminal binding domain (2). The
catalytic domain endows the enzyme with muramidase (13), glu-
cosaminidase (14), transglycosylase (15), alanine-amidase (16),
alanoyl-glutamate endopeptidase (17), glutaminyl-lysine endo-
peptidase (14), or cross-bridge endopeptidase (18) activity. The
binding domain usually recognizes an epitope within the pepti-
doglycan layers of the bacterial cell wall or spore cortex and results
in exquisite species specificity (16). The specificity against individ-
ual bacterial strains is so highly evolved that even a single amino
acid substitution in the binding domain can alter the specificity of
a lysin (19). This species selectivity (16), therefore, allows target-
ing of a single pathogenic strain while preserving commensal mi-
croflora. Moreover, gained resistance against lytic enzymes (and
bacteriophage endolysins) appears to be extremely low compared
to that against antibiotics (2, 16, 20), which represents a significant
motivation for further investigation.
A particularly relevant target of high economic, medical, and
biodefense importance is the spore-forming pathogen Bacillus an-
thracis, the causative agent of anthrax. This pathogen naturally
causes relatively rare infectious outbreaks in humans (21); how-
ever, it gained notoriety after its use as biological weapon in the
Tokyo, Japan, release of 1995 (22) and the intentional spore re-
lease in the U.S. mail in 2001 (23). Given the high cost of decon-
tamination (24) and the recalcitrance of dormant spores (25),
there is acute interest in developing an efficient and targeted ap-
proach to decontamination and treatment. Schuch et al. have ex-
ploited the inherent binding specificity and activity of phage lytic
enzymes for the rapid detection and killing of B. anthracis (16).
They showed that the PlyG endolysin, isolated from the  phage of
B. anthracis, specifically kills B. anthracis isolates and other mem-
bers of the Bacillus cereus group in vitro and in vivo. Both vegeta-
tive cells and germinating spores were found to be susceptible.
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Several other bacteriophage endolysins targeting bacillus
strains have been reported. For example, genes encoding endoly-
sins from B. cereus phages Bastille (PlyBa), TP21 (Ply21), and
12826 (Ply12) were shown to induce rapid and specific lysis of
viable cells of several bacilli, with highest activity against B. cereus
and B. thuringiensis (26). PlyL, a  prophage Ba02 endolysin found
in the genome of Bacillus anthracis, has N-acetylmuramoyl-L-ala-
nine amidase activity and lyses the cell wall of B. anthracis cells
(27). Other cell-lytic enzymes with reported activity against Bacil-
lus anthracis strains include PlyPH and related enzymes (5, 28)
and PlyB (13); these enzymes have been shown to have specific
activity comparable to that of PlyG.
In the current work, using strictly in silico techniques to analyze
the genome of B. anthracis strain Ames with a consensus cell wall
binding domain sequence as a probe, we identified a novel lytic
enzyme (autolysin). We termed the lysin AmiBA2446 based on its
amidase catalytic activity (Ami) and the position of its gene in the
genome of B. anthracis (locus BA2446). We expressed and purified
this protein, confirmed its ability to disrupt the cell walls of vari-
ous Bacillus species, and characterized its specificity and its cata-
lytic properties. AmiBA2446 may be useful for the targeted inac-
tivation of Bacillus cells in various applications.
MATERIALS AND METHODS
Bacterial cell culture and plasmids. B. cereus ATCC 4342, B. cereus
Frankland and Frankland ATCC 10987, Bacillus subtilis ATCC 168, Bacil-
lus thuringiensis subsp. kurstaki ATCC 33679, Bacillus globigii (Bacillus
atrophaeus ATCC 9372), and Staphylococcus aureus ATCC 33807 were
purchased from ATCC. B. cereus Frankland and Frankland 1887 AL (29)
was a kind gift from P. Setlow, University of Connecticut. B. anthracis
Sterne 34F2 was purchased from Colorado Serum Company, Denver, CO.
B. anthracis Sterne was obtained from T. Buhr, NAVSEA Warfare Cen-
ter, Dahlgren, VA.
All bacterial strains used were stored frozen at 80°C in 20% (vol/vol)
glycerol. The frozen glycerol stocks were used to grow cells in Difco nu-
trient broth (Becton Dickinson and Company) at 37°C with aeration at
220 rpm. Microbial cultures (bacilli and S. aureus) were grown at 37°C
with aeration in a 14-ml Falcon tube for 6 h in 4 ml of nutrient broth (3
g/liter beef extract, 5 g/liter peptone) (Difco, Detroit, MI). From this
growing culture, 1 ml was centrifuged at 12,000 rpm for 5 min; the pellet
was then washed twice with phosphate-buffered saline (PBS) to remove
culture medium. Bacteria were then suspended in PBS. The number of
bacterial cells was counted under a microscope (magnification, 400)
using a bacterial cell counting chamber.
Expression and purification of AmiBA2446. The AmiBA2446 gene,
after codon optimization, was cloned in NcoI/XhoI restriction sites in
Escherichia coli plasmid pGS-21a with an N-terminal His tag, followed by
an enterokinase cleavage site (GenScript). BL21 Star(DE3) chemically
competent cells (Invitrogen), optimized for reduced mRNA degradation
and full-length peptide synthesis, were used as an expression host.
AmiBA2446 was expressed and purified using the Native Invitrogen
Pro-Bond protein purification system (Invitrogen). Nickel-chelating
resin was used for purification of recombinant proteins expressed in E. coli
strain BL21 Star(DE3). The overnight culture of E. coli, transformed with
pGS-21a/AmiBA2446 and grown in LB-ampicillin selection medium, was
subcultured at a 1:20 ratio in LB and propagated for 2 h (to reach an
optical density at 600 nm [OD600] of 0.4 to 0.6). Protein expression was
induced by the addition of 0.25 mM IPTG (isopropyl--D-thiogalactopy-
ranoside), and the bacterial suspension was incubated for 2 h at 37°C and
220 rpm. Cells were then pelleted by centrifuging for 20 min at 4000 rpm
at 4°C to remove the medium, resuspended in native purification buffer
containing 1 mM phenylmethylsulfonyl fluoride (PMSF), and then frozen
at 80°C until needed. The cell suspension was then thawed at 37°C and
incubated with lysozyme (100 g/ml) and DNase (10 g/ml) at 4°C for 30
min. The cell suspension was subjected to two more freeze-thaw cycles
and then clarified for 30 min at 4000 rpm at 4°C. The protein was purified
from the clarified soluble fraction under native conditions according to
the manufacturer’s instructions.
Characterization of AmiBA2446 by SEC. Five protein standards were
loaded onto a size exclusion chromatography (SEC) column (Superdex
200 preparative grade; GE Healthcare) using PBS as the running buffer to
obtain a standard equation relating the molecular weight of the protein to
its elution volume. AmiBA2446 was then run on the standardized column
to obtain its elution volume, which was then used to estimate the molec-
ular weight of the protein and provide information about the oligomeric
state of protein under native conditions.
Isolation of peptidoglycan from cell walls of vegetative cells. Prepa-
ration of purified cell wall substrate was carried out as described by Shah
et al. (30). Briefly, cells were grown in 100 ml of nutrient broth medium to
an OD600 of 1.2 and were collected by centrifugation, washed with 0.8%
(wt/vol) NaCl, resuspended in hot 4% (wt/vol) SDS, boiled for 30 min,
and then left at room temperature (RT) overnight. The suspension was
then boiled for 10 min, and the SDS-insoluble cell wall material was col-
lected by centrifugation at 15,000  g for 15 min at RT. The pellet con-
taining cell wall peptidoglycan was washed four times with water and
finally resuspended in 1 ml sterile water.
Cell wall hydrolysis assay. The lytic activity of purified recombinant
endolysins was determined spectrophotometrically, as previously de-
scribed (12, 31). The assays were carried out in polystyrene cuvettes
(Greiner) with a total volume of 1 ml in phosphate-buffered saline (pH
7.4) at room temperature, unless otherwise mentioned. Substrate was
added to an initial OD600 of 0.3 of 0.4 with purified peptidoglycan from
cell walls. At time zero, enzymes were mixed into substrate suspensions to
achieve enzyme concentrations ranging from 3 nM to 3,200 nM, and the
OD600 in each reactor was recorded for up to 30 min (UV-2401PC UV-
visible recording spectrophotometer; Shimadzu). As a negative control,
buffer alone was added and monitored for the same duration.
Kinetics of killing of vegetative bacterial cells. Kinetics were deter-
mined by testing three different concentrations of AmiBA2446 (6 nM, 30
nM, and 150 nM) dosed at time zero into 1 ml of microbial suspensions,
each containing 106 CFU/ml collected at mid-log growth phase (OD600 	
0.5). The number of live cells was determined by removing aliquots from
the microbial suspension after different incubation times (up to 180 min),
diluting them (ca. 50-fold), and spreading them on nutrient agar.
Dose-dependent bacterial killing. The dose dependence of the anti-
microbial activity of AmiBA2446 was determined by treating 1 ml of a
microbial suspension containing 106 CFU/ml with 2 to 480 nM
AmiBA2446 for 3 h. Aliquots from the microbial suspension were col-
lected after 3 h of incubation, diluted (ca. 50-fold), and plated on nutrient
agar. The number of surviving colony-forming bacteria was counted after
overnight incubation. The lytic activity of the enzyme was calculated in
comparison with the colony numbers on untreated controls that were
collected and plated the same way.
Influence of cell density on bacterial killing. The antimicrobial activ-
ity of fixed concentrations of AmiBA2446 enzyme was determined against
105-CFU/ml, 106-CFU/ml, and 107-CFU/ml suspensions of B. cereus cells
by treating 1 ml of the microbial suspension with 60 nM, 600 nM, and 6
M concentrations of AmiBA2446 for 3 h. Colony counts were deter-
mined by plating aliquots from the microbial suspension after 3 h of
incubation on nutrient agar.
Enzyme thermostability analysis. Native enzyme AmiBA2446 was
incubated at different temperatures, and residual activity of the enzyme
was measured using a cell wall hydrolysis assay at regular intervals. A
working enzyme concentration of 600 nM was used to measure the resid-
ual activity, which was expressed as a percentage of the initial activity. To
quantify activity for this comparison, the first-order rate constant, ki, of
inactivation was obtained from a semilogarithmic plot of percent residual
activity versus time. Per the Arrhenius relationship, the activation energy
Mehta et al.
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of inactivation (Eai) was obtained by plotting ln ki against the reciprocal of
temperature, as described by Rajalakshmi and Sundaram (32). The acti-
vation enthalpy (H‡), activation entropy (S‡), and activation free en-
ergy (G‡) of inactivation were calculated using methods described by
Gouda et al. (33).
Enzymatic digestion of peptidoglycan and separation and detection
of released muropeptides using liquid chromatography-mass spec-
trometry (LC-MS). Cell wall peptidoglycan (2 mg/ml) was incubated with
500 g of AmiBA2446 in 1 ml of total solution for 16 h. The supernatant
was collected by spinning the mixture at high speed (18,000  g) for 15
min. The supernatant was then ultrafiltered using a 10-kDa-cutoff mem-
brane to remove the enzyme in the retentate, while the muropeptide re-
leased due to digestion was collected as filtrate. Prior to analysis, the col-
lected muropeptide was reduced with sodium borohydride to prevent
anomerization at the C1 position (34). The digested peptidoglycan was
mixed with 0.5 M borate buffer (pH 8.0) in which NaBH4 (650 mM) had
been freshly dissolved to a final NaBH4 concentration of 130 mM. After 20
min, the reaction was terminated by the addition of phosphoric acid, and
the reaction mixture was brought to a final pH of ca. 4 and filtered (0.2-
m-pore-size filter).
To determine the exact molecular weight of the muropeptides released
during digestion, the digested peptidoglycan was analyzed by LC-tandem
MS (LC-MS/MS) using an Agilent 1200 high-pressure liquid chromato-
graph (HPLC) (Agilent Technologies, CA) coupled to an LTQ-Orbitrap
hybrid mass spectrometer (Thermo Scientific, Bremen, Germany). Mu-
ropeptide separation was accomplished using a C18 reverse-phase column
(Thermo Scientific Bio Basic C18; 100 by 2.1 mm, 5 m) at a flow rate of
200 l/min. The solvents were 0.2% formic acid in water (buffer A) and
20% acetonitrile– 0.2% formic acid (buffer B). A linear gradient from
0% to 67% (vol/vol) of buffer B (for 0 to 60 min) was used. The mass
spectrometer was operated in electrospray ionization mode with de-
tection of positively charged ions in the m/z range 300 to 1800 at a
resolution of 30,000 and accuracy of mass measurements of 2
ppm. The data-dependent acquisition mode was used to obtain colli-
sion-induced dissociation mass spectra of the three most intense peaks
of multiply charged ions.
RESULTS
Identification of AmiBA2446. We based our strategy to identify
novel phage lytic enzymes targeting B. anthracis on the observa-
tion that the majority of lytic enzymes have a modular structure
that consists of a catalytic domain and a binding domain, con-
nected by a short linker. The binding domain confers species spec-
ificity by recognizing peptidoglycan motifs in the bacterial cell
wall (35). We built a consensus binding domain sequence to rec-
ognize the cell wall of B. anthracis by aligning the sequences of the
known enzymes PlyG (16) and PlyPH (28) (see Fig. S1 in the
supplemental material). Next, we performed a homology search
against the genome of B. anthracis strain Ames in the NCBI data-
base (ASM784v1, bioproject PRJNA57909) (36). We identified
four highly homologous hits with E values of  1020. The low E
value indicates a low probability that these homologies occurred
by chance (see Fig. S1c in the supplemental material).
Three of the four sequences were either reported or were
highly homologous to already reported lytic enzymes. Se-
quence NP844822, however, was dissimilar to both PlyG and
PlyPH. In silico analysis of the protein sequence using the Con-
served Domain Database at NCBI (37–39) led to the supposi-
tion that the protein was an N-acetylmuramoyl-L-alanine ami-
dase (also known as MurNAc-LAA, peptidoglycan amidase; EC
3.5.1.28). We termed the lysin AmiBA2446 based on its ami-
dase catalytic activity and the position of its gene in the genome
of B. anthracis (locus BA2446). The sequence of AmiBA2446
can be retrieved from the GenBank database (ncbi.nlm.nih.gov
/GenBank) as NP844822 or as ZP00392698 within the genome of
B. anthracis Ames strain A2012. In summary, AmiBA2446 is a
245-amino-acid protein that shares homology of the C-terminal
binding domain with PlyPH and PlyG but has a highly dissimilar
catalytic domain (see Fig. S2 in the supplemental material).
Recombinant AmiBA2446 expressed in E. coli and purified
from other lysate proteins showed a single band on SDS-PAGE, at
a molecular weight corresponding to that of a monomeric protein
(see Fig. S3 in the supplemental material). Size exclusion studies
suggested that AmiBA2446 existed in its native form as a dimer
(see Fig. S4 in the supplemental material).
Phylogenic analysis. A phylogenic tree was constructed to es-
tablish the evolutionary localization of AmiBA2446 relative to the
detected open reading frames (ORFs) in the NCBI genome data-
bank (Fig. 1). Over 90% of the AmiBA2446 homologs were auto-
lysins of predicted bacterial origin. Only seven of the evolution-
arily closest enzymes were of bacteriophage origin.
Biochemical properties of AmiBA2446. The lytic activity of
AmiBA2446 was first quantified using the B. cereus cell wall hy-
drolysis assay by monitoring changes in the optical density of a
suspension of cell wall peptidoglycan fragments. Absorbance at
600 nm was observed to decrease over time due to the action of
AmiBA2446. The enzymatic degradation of B. cereus cell wall ma-
terial was highly nonlinear as a function of AmiBA2446 concen-
tration (see Fig. S5a in the supplemental material). AmiBA2446
did not follow the typical saturation kinetics (see Fig. S5b in the
supplemental material). Based on the initial rate data, the ob-
served Vmax/Km ratio was 1.79  10
6 min1. The enzyme activity
(based on the cell wall hydrolysis assay) was optimal at pH 7.0 (see
Fig. S6a in the supplemental material). Interestingly, AmiBA2446
activity was highly dependent on the concentration of NaCl, with
activity decreasing by 80% as the NaCl concentration increased
from 50 to 500 mM (see Fig. S6b in the supplemental material).
Antimicrobial activity of AmiBA2446. The bactericidal activ-
ity of AmiBA2446 was demonstrated by treating 106 CFU/ml of B.
cereus 4342 cells (OD600 	 0.5) with enzyme at concentrations
ranging from 2 nM to 480 nM. This strain is commonly used as a
surrogate for pathogenic B. anthracis strains (40, 41). We observed
up to ca. 99.9% (3-log) killing (Fig. 2a). To quantify AmiBA2446
kinetics, we treated 106 CFU/ml B. cereus cells with three different
enzyme concentrations (6, 30, and 150 nM) and then determined
the number of live cells at each concentration. Enzyme quantities
expected to yield stronger concentration dependence were se-
lected based on the results in Fig. 2a. Indeed, as the concentration
of enzyme increased, so did the rate of cell killing, with up to an
3-log reduction in viable bacterial cells obtained with 150 nM
AmiBA2446 after 3 h (Fig. 2b).
We observed a correlation between the phase of bacterial
growth and the bactericidal effect exerted by the enzyme. A rapidly
dividing bacterial culture in mid-log phase (OD600 	 0.5) during
the initial hours of expansion was markedly more sensitive than an
overnight culture in stationary phase (Fig. 3). We further explored
the maximal bactericidal activity achievable with this treatment
on a rapidly dividing bacterial culture. We varied both the
AmiBA2446 concentration and the initial concentration of B. ce-
reus cells and found that the reduction in viable cells was 3 to 4
logs (Fig. 4). Moreover, the extent of cell killing achieved was even
higher, close to 5 logs, during the very early growth phase (OD 
0.25).
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We tested AmiBA2246 against a panel of closely related and
unrelated species (Table 1). AmiBA2446 was highly effective
against both tested strains of B. anthracis, B. cereus 4342, and B.
thuringiensis; however, it was not effective against the more distant
B. subtilis, B. globigii, two other strains of B. cereus, and S. aureus.
We also tested the activity of AmiBA2446 against spores of the
B. anthracis Sterne 34F2 after treating them with germinants. As
expected, the enzyme had no activity against the spores in the
absence of germinants (Fig. 5). However, exposure of the spores to
tryptic soy broth containing 10 mM L-alanine and 5 mM inosine
for 2 h, followed by treatment with enzyme, resulted in a 84%
decrease in the number of viable spores. We note that enzyme-
based sporicidal activity relies on spore germination and that the
surviving spores may not have germinated in the 2 h of pretreat-
ment used in this experiment.
Storage and thermal stability. AmiBA2446 retained 95% of
its initial activity after storage at room temperature for more than
4 months (Fig. 6). The residual enzymatic activity of AmiBA2446
at different temperatures over a period of time (see Fig. S7 in the
supplemental material) showed its activation energy of inactiva-
tion (Eai) to be  174 kJ mol
1 (see Fig. S8 in the supplemental
material). The Eai of AmiBA2446 is comparable to those reported
for trypsin, chymotrypsin, and papain (32, 42, 43), suggesting that
its thermostability is comparable to those of these moderately sta-
ble proteases. The activation enthalpy (H‡), activation entropy
(S‡), and activation free energy (G‡) at different temperatures
were calculated and did not show any significant dependence on
temperature (see Table S1 in the supplemental material). Interest-
ingly, comparing the thermostability of AmiBA2446 with those of
other bacteriolytic enzymes highlights its superior thermostabil-
ity. For instance, AmiBA2446 retained its activity for at least 24 h
at 50°C, while Cpl-1, a phage lytic enzyme against Streptococcus
pneumoniae, has been shown to be stable for only 30 min at 45°C
(44).
N-Acetylmuramoyl-L-alanine amidase activity of AmiBA2446.
Analysis of the AmiBA2446 sequence using BLASTP revealed con-
served domains that suggested an enzymatic activity identical to
that of an N-acetylmuramoyl-L-alanine amidase (also known as
FIG 1 Phylogenic relationship of AmiBA2446 to lytic enzymes originating from Bacillus species and their phages. The scale bar indicates the evolutionary
distance between the sequences, 20 amino acids, relative to the hypothetical common ancestor. The location of AmiBA2446 is indicated with filled arrow, and the
enzymes of bacteriophage origin are indicated with empty arrows; the rest of the homologs are predicted autolysins.
Mehta et al.
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MurNAc-LAA, peptidoglycan amidase; EC 3.5.1.28), a putative
endolysin that hydrolyzes the amide bonds between N-acetylmu-
ramic acid and L-amino acids in the cell wall. We analyzed muro-
peptides released from the cell wall peptidoglycan due to enzy-
matic treatment using LC-MS (Fig. 7a and b) and confirmed that
AmiBA2446 has N-acetylmuramoyl-L-alanine amidase activity.
DISCUSSION
Lytic enzymes from both phage and bacterial origin have been
successfully shown to be potent bactericidal agents (5–8). Our
strategy to use a consensus binding domain sequence that recog-
nizes the cell wall of B. anthracis as a probe and the subsequent in
silico analysis of the B. anthracis genome led to the identification of
a novel lytic enzyme, AmiBA2446. We performed a database-wide
analysis to determine whether any closely related species had
similar protein sequences encoded in their genomes. We found
that B. cereus ATCC 4342, which is genetically similar to B.
anthracis, has an identical sequence, termed ZP04284115. In
bacteriophages, the Bacillus phage BCP78 has a 272-amino-
acid sequence (GenBank accession number AEW47021) with
74% homology to AmiBA2446 (45), and the phage M19-encoded
lytic protein had 70% homology to AmiBA2446. The protein
encoded by environmental sample phage M19 (accession number
ADF97544) was shown to be catalytically active in a clearing zone
assay when tested against autoclaved Pseudomonas aeruginosa cells
(20).
Our experiments demonstrated that AmiBA2446 exists as a
homodimer. This result is consistent with previous reports of the
dimerization of the consensus binding domain of another en-
zyme, PlyG (Protein Data Bank [PDB] number 2L48) (J. S. Dias,
F. C. Peterson, and B. F. Volkman, unpublished results). PlyG and
AmiBA2446 have the same modular structure and share highly
homologous binding domain sequences, rendering the compari-
son valid. The dimerization of the binding domains of PlyG and
AmiBA2446 does not prove that these enzymes necessarily func-
tion as dimers in nature. For instance, the full-length PlyG has
been reported to exist as a stable monomer based on size exclusion
FIG 2 (a) Dose dependence of bacterial killing for AmiBA2446 against 106
CFU/ml of B. cereus cells. (b) Kinetics of AmiBA2446 activity against B. cereus
cells at different enzyme concentrations. , PBS; , 6 nM AmiBA2446; Œ, 30
nM AmiBA2446; , 150 nM AmiBA2446. The values are averages from three
independent experiments.
FIG 3 Susceptibility of a bacterial culture to killing by AmiBA2446 (600 nM)
as a function of bacterial growth kinetics.
FIG 4 Bacterial killing for AmiBA2446 against various concentration of B.
cereus cells. , 105 CFU/ml; , 106 CFU/ml; , 107 CFU/ml. The values are
averages from three independent experiments.
TABLE 1 Bactericidal specificity of AmiBA2446a
Bacterial strain
Lytic activity
(%)
Bacillus cereus ATCC 4342 99.9
Bacillus anthracis Sterne 99.9
Bacillus anthracis Sterne 34F2 99.5
Bacillus thuringiensis subsp. kurstaki ATCC 33679 98.4
B. cereus Frankland and Frankland 1887 AL 50
B. cereus Frankland and Frankland ATCC 10987 0
Bacillus subtilis ATCC 168 0
Bacillus globigii (Bacillus atrophaeus ATCC 9372) 0
Staphylococcus aureus ATCC 33807 0
a All bacteria were grown in nutrient broth to an OD600 of 0.5, and for each strain,
106 CFU/ml of its cell suspension was treated with 600 nM AmiBA2446 for 3 h.
Bacteriolytic Enzyme Active against Bacillus Species
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studies (16), while our work suggests that AmiBA2446 exists as a
stable homodimer.
Our biochemical studies showed that the enzymatic degrada-
tion of B. cereus cell wall material was highly nonlinear as a func-
tion of AmiBA2446 concentration (see Fig. S4a in the supplemen-
tal material). This result was not unexpected, as the cell wall
represents a highly heterogeneous substrate. Thus, easily hydro-
lyzable linkages (e.g., those that may have greater accessibility) are
easily cleaved, leading to a relatively high rate of hydrolysis. Less
reactive/accessible bonds remain recalcitrant to hydrolysis even at
higher enzyme concentrations (46). AmiBA2446 did not follow
typical saturation kinetics (see Fig. S5b in the supplemental mate-
rial). Due to substrate heterogeneity and the varying degree of
polymerization seen in the cell wall, there are relatively few sites
that are easily accessible, and there are likely far more sites that are
poorly accessible. Such a situation is similar to that observed with
heterogeneous cellulose hydrolysis catalyzed by cellulases, which
would favor more linear reactivity as a function of substrate con-
centration (46–48).
The species specificity of the lytic enzymes is an advantage over
broad-spectrum antibiotics, which can adversely affect commen-
sal microflora. We found that AmiBA2446 was active against a few
closely related Bacillus strains. The bactericidal activity against B.
cereus 4342 and B. thuringiensis is likely attributable to their close
genetic similarity to B. anthracis (40, 41, 49). Indeed, B. cereus
4342 is commonly used as an experimental surrogate strain for B.
anthracis (40). The relatively modest activity (50% killing) against
B. cereus Frankland and Frankland 1887 AL and the lack of activity
against B. cereus Frankland and Frankland ATCC 10987 is likely
due to the considerable difference between the structures of its cell
wall peptidoglycan and that of B. anthracis (50). Moreover,
AmiBA2446 was not effective against the more distant B. subtilis,
B. globigii, and S. aureus, thereby confirming the specificity of the
enzyme. Our results are consistent with those observed for other
lytic enzymes, PlyG (16) and PlyPH (28), which is expected, given
the homology between the binding domains of AmiBA2446, PlyG,
and PlyPH (see Fig. S1 and S2 in the supplemental material).
In conclusion, as more bacterial pathogens become resistant
to available antibiotics, new agents must be developed. The ap-
proach used to identify and characterize AmiBA2446 repre-
sents an example of how to expand, perhaps dramatically, the
repertoire of highly selective bactericidal agents. The high sta-
bility of AmiBA2446 of at least 4 months in solution further ex-
pands the potential for its commercial use. Indeed, the approach
used in this work could enable the effective decontamination of
any resistant bacterial pathogen by sequencing its genome and
using bioinformatics to identify putative lytic enzymes. Given that
such an enzyme would be found encoded within the genome of a
FIG 5 Sporicidal effect of AmiBA2446 on B. anthracis spores in the presence
or absence of germinants. The values are averages from three independent
experiments.
FIG 6 Storage stability of AmiBA2446 at room temperature in aqueous so-
lution.
FIG 7 N-Acetylmuramoyl-L-alanine amidase activity of AmiBA2446 deter-
mined using LC-MS analysis. (a) Elution profile of muropeptide fragments
released after digestion of peptidoglycan using AmiBA2446. (b) Peptidogly-
can structure of the B. cereus cell wall. The results indicate that AmiBA2446
has N-acetylmuramoyl amidase activity (26). A, amidase; TriP, tripeptide
consisting of L-Ala–D-Glu– diaminopimelic acid; TP, tetrapeptide consist-
ing of L-Ala–D-Glu– diaminopimelic acid–D-Ala; TriP-TP, TriP cross-
linked through its diaminopimelic acid to D-Ala of TP. Ovals indicate the
muropeptide fragments expected to release as a result of amidase activity.
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target pathogen and likely would serve a metabolic function, it is
unlikely that gained resistance will rapidly emerge. It has been
proposed that lytic enzymes have evolved to target nonredundant
defense features within the peptidoglycan cell wall, thus making it
unlikely for the target microbes to develop efficient mechanisms
of resistance to lytic enzyme activity (2, 12). This approach, there-
fore, may be important for addressing the growing concern posed
by antimicrobial resistance and could be very useful in future ap-
plications (51–53).
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